Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins
Multiple pregnancy rate · ovulation induction in polycystic ovarian syndrome
Recombinant follicle stimulating hormone showed no clear difference in incidence of multiple pregnancy (per woman) compared with urinary‐derived gonadotrophins (low certainty).
1 finding from 1 review
- Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes onlyRR 0.86 [0.46, 1.61]8 studies · 1368 participantsLow